An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgical patients

被引:76
|
作者
Fierobe, L
Lucet, JC
Decré, D
Muller-Serieys, C
Deleuze, A
Joly-Guillou, ML
Mantz, J
Desmonts, JM
机构
[1] Univ Lyon 1, Hop Bicetre, Dept Anesthesiol & Intens Care, F-75018 Paris, France
[2] Univ Lyon 1, Hop Bicetre, Infect Control Unit, F-75018 Paris, France
[3] Univ Lyon 1, Hop Bicetre, Dept Microbiol, F-75018 Paris, France
来源
关键词
D O I
10.1086/501822
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE: To describe an outbreak of imipenem-resistant Acinetobacter baumannii (IR-Ab) and the measures for its control, and to investigate risk factors for IR-Ab acquisition. DESIGN: An observational and a case-control study. SETTING: A surgical intensive care unit (ICU) in a university tertiary care hospital. METHODS: After admission to the ICU of an IR-Ab-positive patient, patients were prospectively screened for IR-AI, carriage upon admission and then once a week. Environmental cleaning and barrier safety measures were used for IR-Ab carriers. A case-control study was performed to identify factors associated with hi-Ah acquisition. Cases were patients who acquired IR-Ab. Controls were patients who were hospitalized in the ICU at the same time as cases and were exposed to IR-Ab for a similar duration as cases. The following variables were investigated as potential risk factors: baseline characteristics, scores for severity of illness and therapeutic intervention, presence and duration of invasive procedures, and antimicrobial administration. RESULTS: Beginning in May 1996, the outbreak involved 17 patients over 9 months, of whom 12 acquired TR-Ab (cases), 4 had IR-Ab isolates on admission to the ICU, and 1 could not be classified. Genotypic analysis identified two different IR-Ab isolates, responsible for three clusters. Ten of the 12 nosocomial cases developed infection. Control measures included reinforcement of barrier safety measures, limitation of the number of admissions, and thorough environmental cleaning. No new case was identified after January 1997. Eleven of the 12 cases could be compared to 19 controls. After adjustment for severity of illness, a high individual therapeutic intervention score appeared to be a risk factor for IR-Ab acquisition. CONCLUSION: The outbreak ended after strict application of control measures. Our results suggest that high work load contributes to IR-Ab acquisition (Infect Control Hasp Epidemiol 2001;22:35-40).
引用
收藏
页码:35 / 40
页数:6
相关论文
共 50 条
  • [31] The Cost of Responding to an Acinetobacter Outbreak in Critically Ill Surgical Patients
    Jiang, Yushan
    Resch, Stephen
    Liu, Xiaoxia
    Rogers, Selwyn O., Jr.
    Askari, Reza
    Klompas, Michael
    Jayaraman, Sudha P.
    SURGICAL INFECTIONS, 2016, 17 (01) : 58 - 64
  • [32] Pseudo-outbreak of imipenem-resistant Acinetobacter baumannii resulting from false susceptibility testing by a rapid automated system
    Tsakris, A
    Pantazi, A
    Pournaras, S
    Maniatis, A
    Polyzou, A
    Sofianou, D
    JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) : 3505 - 3507
  • [33] In vitro evaluation of antimicrobial combinations against imipenem-resistant Acinetobacter baumannii of different MICs
    Zhu, Wan
    Wang, Yang
    Cao, Wenxia
    Cao, Shiyue
    Zhang, Jingping
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2018, 11 (06) : 856 - 860
  • [34] Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain:: a nationwide study
    Cisneros, JM
    Rodríguez-Baño, J
    Fernández-Cuenca, F
    Ribera, A
    Vila, J
    Pascual, A
    Martínez-Martínez, L
    Bou, G
    Pachón, J
    CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (11) : 874 - 879
  • [35] Characterization of imipenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates in a Moroccan hospital
    Benaissa, Elmostafa
    Abassour, Tilila
    Belouad, Elmehdi
    Maleb, Adil
    Elouennass, Mostafa
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2022, 69 (02) : 118 - 126
  • [36] Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii:: a case-control study
    Lee, SO
    Kim, NJ
    Choi, SH
    Kim, TH
    Chung, JW
    Woo, JH
    Ryu, J
    Kim, YS
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) : 224 - 228
  • [37] In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates
    Tan, Thean Yen
    Ng, Lily Siew Yong
    Tan, Eugene
    Huang, Gary
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (02) : 421 - 423
  • [38] Cost-analysis of an intensive care unit closure due to an imipenem-resistant oxa-23 Acinetobacter baumannii outbreak
    Garlantezec, R.
    Bourigault, C.
    Boles, J. M.
    Prat, G.
    Baron, R.
    Tonnelier, J. M.
    Cosse, M.
    Lefevre, M.
    Jourdain, S.
    Lelay, G.
    Daniel, L.
    Virmaux, M.
    Le Du, I.
    Tande, D.
    Renault, A.
    Lejeune, B.
    JOURNAL OF HOSPITAL INFECTION, 2011, 77 (02) : 174 - 175
  • [39] Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit
    Pournaras, S
    Markogiannakis, A
    Ikonomidis, A
    Kondyli, L
    Bethimouti, K
    Maniatis, AN
    Legakis, NJ
    Tsakris, A
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (03) : 557 - 561
  • [40] Colonization pressure and risk factors for acquisition of imipenem-resistant Acinetobacter baumannii in a medical surgical intensive care unit in Brazil
    Castelo Branco Fortaleza, Carlos Magno
    de Freitas, Fernanda Moreira
    Lauterbach, Gerhard da Paz
    AMERICAN JOURNAL OF INFECTION CONTROL, 2013, 41 (03) : 263 - 265